National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Christensen AH(2024) Can sinoatrial reinnervation improve survival after heart transplantation? J Heart Lung Transplant(in press) DOI 10.1016/j.healun.2024.11.004, PubMed 39557315
Ankill J, Zhao Z, Tekpli X, Kure EH, Kristensen VN, Mathelier A, Fleischer T(2024) Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation PLoS Comput Biol, 20(11), e1012565(in press) DOI 10.1371/journal.pcbi.1012565, PubMed 39556603
Kleppe A, Lindemann K, Kildal W, Tobin KAR, Pradhan M, Vlatkovic L, Isaksen MX, Danielsen HE, Askautrud HA, Kristensen GB(2024) Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer Gynecol Oncol, 192, 80-88(in press) DOI 10.1016/j.ygyno.2024.11.005, PubMed 39549540